Tech Company Financing Transactions

CAMP4 Therapeutics Funding Round

CAMP4 Therapeutics, based in Cambridge, secured $100 million from Enavate Sciences, 5AM Ventures and Andreessen Horowitz.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

1 Kendall Sq. Bldg 1400 West 3rd Floor
Cambridge, MA 02139
USA

Phone

Undisclosed

Website

www.camp4tx.com

Email Address

[email protected]

Overview

CAMP4 is focused on addressing the fundamental cause of disease by controlling the output of genes central to disease. By taking advantage of the gene circuitry code, CAMP4 is able to control gene production through signaling pathways the cell is already utilizing to regulate gene expression.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Josh Mandel-Brehm

        

Chief Scientific Officer

David Bumcrot

        

Vice President

Alfica Sehgal

        

VP - Bus. Development

Kelly Gold

        

VP - Human Resources

Michelle Gates

        

VP - Operations

Caleb Moore

        

Browse more venture capital transactions:

Prev: 7/20/2022: Priori Legal venture capital transaction
Next: 7/20/2022: Electrified Thermal Solutions venture capital transaction

Share this article

About Our VC Transactions Data

We do our best to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary